Serum pepsinogen test for early detection of gastric cancer in a European Country

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 1, 2012, Pages 37-41

  Lomba Viana, Rafael ^a   Dinis Ribeiro, Mário ^b   Fonseca, Fernando ^a   Vieira, Anabela Silva ^a   Bento, Maria José Bento ^b   Lomba Viana, Helena ^c  

^a Vila Do Conde Hospital   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c Porto Military Hospital   (Portugal)

Author keywords

Accuracy; Gastric cancer; Pepsinogen test; Screening

Indexed keywords

PEPSINOGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERUM PEPSINOGEN TEST; STOMACH BIOPSY; STOMACH CANCER; UPPER GASTROINTESTINAL TRACT;

ADULT; AGED; EARLY DETECTION OF CANCER; EPIDEMIOLOGIC METHODS; FEMALE; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PEPSINOGEN A; PEPSINOGEN C; PORTUGAL; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 82555169683     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834d0a0a     Document Type: Article

References (38)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12:354-362. (Pubitemid 43329250)
2. Roder D. The epidemiology of gastric cancer. Gastric Cancer 2002; 5 (Suppl 1):5-11. (Pubitemid 36604663)
3. Parkin DM, Bary FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8):S4-S66.
4. Miki K, Fujishiro M, Kodashina S, Yahagi N. Long term results of gastric cancer screening using serum pepsinogen test method among in asymptomatic middle-aged Japanese population. Dig Endosc 2009; 21:78-81.
5. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T. The Japanese guidelines for gastric cancer screening. J Clin Oncol 2008; 38:259-267. (Pubitemid 351583989)
6. Inaba S, Hiroyama H, Nagata C, Kurisu Y, Takatsuka N, Kawakami N, Shimizu H. Evaluation of a screening program on reduction of gastric cancer mortality in Japan: preliminary results from a cohort study. Prev Med 1999; 29:102-106.
7. Mizoue T, Yoshimira T, Tokui N, Hoshiyama Y, Yatsuya H, Sakata K, et al. Prospective study of screening for stomach cancer in Japan. Int J Cancer 2003; 106:103-107. (Pubitemid 36750395)
8. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, et al.; JPHC Study Group. Gastric cancer screening and subsequent risk of gastric cancer: a large scale population based cohort study with a 13 years followup in Japan. Int J Cancer 2006; 118:2315-2321.
9. Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, et al. Cancer high-risk subjects identified by serum pepsinogen test: outcomes after 10 years follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 2008; 17:838-845. (Pubitemid 351536414)
10. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using serum pepsinogen test method. Am J Gastroenterol 2003; 98:735-739. (Pubitemid 36576295)
11. Yoshiara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, Haruma K. Reduction in gastric cancer mortality by screening base on serum pepsinogen concentration: a case control study. Scand J Gastroenterol 2007; 42:1-5.
12. Ichinose M, Yahagi N, Oka M, Ikeda H, Miki K, Omata M. Screening for gastric cancer in Japan. In: Wugy GY, Aziz K, editors. Cancer screening. Totowa (NJ): Human Press. 2001; pp. P255-P268.
13. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 2006; 9:245-253. (Pubitemid 44846546)
14. Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007; 8:8-14. (Pubitemid 46189204)
15. Lee YC, Lin JT, Wu HM, Liu TY, Yen MF, Chiu HM, et al. Cost-efectiveness analysis between primary and secondary preventive strategies for gastric cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:875-885.
16. Mizuno S, Kobayashi M, Tomita S, Miki I, Masuda A, Onoyama M, et al. Validation of the pepsinogen test method for gastric cancer using a followup study. Gastric Cancer 2009; 12:158-163.
17. Roreno. Registo Oncológico Regional do Norte 2006. I.P.O. Porto, Eds, November 2010.
18. Quina MG. Helicobacter pylori: the portuguese scene. Eur J Cancer Prev 1994; 3 (Suppl 2):65-67.
19. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19 (Suppl):S37-S43.
20. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis 2007; 8:15-22. (Pubitemid 46189205)
21. Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005; 96:713-720. (Pubitemid 41723549)
22. Miki K, Fujishiro M. Cautious comparison between East andWest is necessary in terms of the serum pepsinogen test. Dig Endosc 2009; 11:134-135.
23. Dinis Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11:141-147. (Pubitemid 39274096)
24. Alberts SR, Cervantes A, Van Develde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003; 14 (Suppl 2):ii31-ii36. (Pubitemid 36874136)
25. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44:693-697. (Pubitemid 29195918)
26. Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, et al. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study. Am J Epidemiol 2006; 163:629-637.
27. Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, et al. Helicobacter pylori infection and gastric cancer. A nested case control study in a rural area of Japan. Dig Dis Sci 1997; 42:1383-1387. (Pubitemid 27339350)
28. Watase H, Inagaki T, Yoshikawa I, Furihata S,Watanabe Y, Miki K, et al. Five years' follow up of participants in stomach cancer screening by serum pepsinogen method. J Assoc Cancer Detect Diagn 2004; 11:141-147.
29. Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, FärkkiläM, Haapiainen R, Kosunen TU. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13 C-urea breath test and serology. Scand J Gastroenterol 2000; 35:138-141. (Pubitemid 30216581)
30. Kikuchi S, Kurosawa M, Sakiyama T, Tenjin H, Miki K, Wada O, Inaba Y. Long-term effect of Helcobacter pylori infection on serum pepsinogen. J Cancer Res 2000; 9:474-476.
31. Watabe H, Mitsushima T, Yamagi Y, Okamoto M, Wada R. Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54:764-768. (Pubitemid 40732089)
32. Miki K, Nomura AMY, Klonel LN, Miki K, Stermmermann GN,Wilken LR, et al. The relationship between Helicobacter pillory, pepsinogen and gastric adenocarcinoma. Gut 2005; 54 (Suppl VII):A-10.
33. Kwon YM, Lim HT, Lee K, Cho BL, Park MS, Son KY, Park SM. Factors associated with use of gastric cancer screening services in Korea. World J Gastroenterol 2009; 15:3653-3659.
34. Muto M, Saito Y, Koike T, Miki K. A case of gastric cancer with high pepsinogen levels in both serum and ascites. Dig Endosc 2000; 12:42-45. (Pubitemid 30195512)
35. Lynch HT, Grady W, Suriano G, Huntsman D. New genetic developments. J Surg Oncol 2005; 90:114-133.
36. Nardone G, Rocco A, Malfertheiner P. Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004; 20:261-270. (Pubitemid 39062128)
37. Ohata H, Kitauch S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with HELICOBACTER pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109:138-143. (Pubitemid 38160674)
38. Correa P. Human gastric carcinogenesis: a multi-step and multi-factorial process. First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52:6735-6740.